There's a boom in the use of weight loss medications with more new ones on their way, but they are recommended only for the clinically obese. A slew of new weight loss drugs are being tested in 2025.

He adds that duloxetine is another medication that can also be used, especially if there is a contraindication to NSAIDs.

PORTLAND, KS, UNITED STATES, February 13, 2025 /EINPresswire / -- Rheumatoid arthritis is an autoimmune disorder, w ...

Ahead of RFK Jr.’s confirmation as head of the HHS, Dr. Dino Prato spoke about what is putting people’s health at risk — and ...

Healthcare inflation outpaces CPI due to provider shortages. Find out why income investing ensures steady returns despite ...

Yet the majority (60%) have not formally disclosed their conditions to their employer.

Discover how GLP-1 weight loss medications like Ozempic and Wegovy are linked to reduced risks of dementia heart disease and more—alongside potential side effects to consider ...

Joint Pain Injections Market Research Report In 2021, the joint pain injections market was valued at approximately $6.27 billion and is pro ...

Taylor Thompson says women should eat healthy, exercise and consume less alcohol to avoid cardiovascular issues like heart ...

Obesity is a growing concern, affecting bone and joint health through increased stress and inflammation. We got in touch with ...

As dogs grow older, their nutritional needs change significantly. Just like humans, senior dogs require a diet that supports ...